MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer. Bangladesh Journal of Pharmacology, [S. l.], v. 10, n. 3, p. 524–528, 2015. DOI: 10.3329/bjp.v10i3.23076. Disponível em: https://www.banglajol.info/index.php/BJP/article/view/23076. Acesso em: 29 jun. 2026.